A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

Podobne knjige/članki

• Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen
  od: Berinstein, Neil L., et al.
  Izdano: (2011)
• IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
  od: Wolf, Gregory T, et al.
  Izdano: (2018)
• Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
  od: Berinstein, Neil L., et al.
  Izdano: (2018)
• NOVEL NEOADJUVANT IMMUNOTHERAPY REGIMEN SAFETY AND SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CANCER
  od: Wolf, Gregory T., et al.
  Izdano: (2011)
• Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen
  od: Naylor, Paul H., et al.
  Izdano: (2011)